Suppr超能文献

吩噻嗪:一种更好的抗结核支架。

Phenothiazine: A Better Scaffold against Tuberculosis.

机构信息

Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India.

出版信息

Mini Rev Med Chem. 2018;18(17):1442-1451. doi: 10.2174/1389557517666170220152651.

Abstract

The incidence of Tuberculosis (TB) is baffling in developing countries due to the increase in multidrug-resistant and extensively drug-resistant TB. Therefore, drugs acting through different mechanisms are in dire need to counter the resistant strains. Various chemical scaffolds are being investigated against tuberculosis, among them the molecules containing phenothiazine nucleus are found to be more effective against both susceptible and resistant strains of M. tuberculosis. In addition, the efficacy of first-line drugs has been found to be enhanced on supplementary treatment with phenothiazines. The present review provides an overview of the phenothiazine based molecules which were investigated during the last ten years for their anti-tubercular activity.

摘要

由于耐多药和广泛耐药结核病的增加,发展中国家的结核病发病率令人费解。因此,急需作用机制不同的药物来对抗耐药菌株。人们正在研究各种针对结核病的化学支架,其中含有吩噻嗪核的分子被发现对结核分枝杆菌的敏感株和耐药株都更有效。此外,还发现联合使用吩噻嗪类药物可增强一线药物的疗效。本综述概述了过去十年中研究过的基于吩噻嗪的分子,它们具有抗结核活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验